Press Releases

Evotec and CHDI Foundation Extend Strategic Drug Discovery Collaboration in Huntington’s Disease May 28, 2024 01:50AM

• Longstanding alliance between Evotec and CHDI to enable the development of therapeutics for Huntington's disease
• One of Evotec's largest strategic drug discovery alliances

HAMBURG, GERMANY / ACCESSWIRE / May 28, 2024 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) has announced the extension of its 20-year collaboration with CHDI Foundation, Inc. ("CHDI"). CHDI is a privately funded nonprofit biomedical research organisation... (continue reading...)

Vecima Networks Inc. Announces Financing of up to C$32 Million having received Commitments for C$27.5 Million May 28, 2024 01:32AM

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.

VICTORIA, British Columbia--(BUSINESS WIRE)-- Vecima Networks Inc. (TSX:VCM) (“Vecima” or the “Company”) is pleased to announce a financing of up to C$32,000,000, having received subscription agreements in connection with a brokered private placement of 833,200 subscription... (continue reading...)

Sensorion Announces its Participation in Upcoming Investor Conferences in June 2024 May 28, 2024 01:30AM

MONTPELLIER, France--(BUSINESS WIRE)-- Regulatory News:

Sensorion (FR0012596468 – ALSEN) (Paris:ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, today announces its participation in various investor conferences taking place in June 2024.

Sensorion will participate in Jefferies Global Healthcare Conference, taking place on... (continue reading...)

BGHL (GBP): NAV(s) May 28, 2024 01:30AM

                                      BOUSSARD & GAVAUDAN HOLDING LIMITED

Ordinary Shares

The Directors of Boussard & Gavaudan Holding Limited would like to announce the following information for the Company.

Close of business 27 May 2024.

Estimated NAV

 Euro SharesSterling SharesEstimated NAV€    27.8939£    25.0014Estimated MTD return     0.75 %     0.83 %Estimated YTD return     1.26 %     1.76... (continue reading...)

BGHL (EUR): NAV(s) May 28, 2024 01:30AM

                                      BOUSSARD & GAVAUDAN HOLDING LIMITED

Ordinary Shares

The Directors of Boussard & Gavaudan Holding Limited would like to announce the following information for the Company.

Close of business 27 May 2024.

Estimated NAV

 Euro SharesSterling SharesEstimated NAV€    27.8939£    25.0014Estimated MTD return     0.75 %     0.83 %Estimated YTD return     1.26 %     1.76... (continue reading...)